Literature DB >> 19691031

Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art.

Gordon J G Asmundson1, Joel Katz.   

Abstract

The purpose of this article is to describe the current state-of-the-art regarding the co-occurrence of the anxiety disorders and chronic pain. First, we describe the core characteristics of chronic pain and its co-occurrence with the anxiety disorders. Second, we review data on the prevalence of co-occurrence. Third, we describe the mutual maintenance and shared vulnerability models, both of which have been offered to explain the co-occurrence of posttraumatic stress disorder (PTSD) and chronic pain and may have applicability to various other anxiety disorders. Fourth, we provide an integrative review of available research addressing the postulates of these models specific to the mechanisms of anxiety sensitivity, selective attention to threat, and reduced threshold for alarm. We conclude with general recommendations for improving assessment and treatment of patients who present with an anxiety disorder accompanied by clinically significant pain. Given that most of the available evidence has come from studies of PTSD and chronic pain, we provide a detailed agenda for future investigation of the co-occurrence of chronic pain and other anxiety disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19691031     DOI: 10.1002/da.20600

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  189 in total

1.  The relation of PTSD symptoms to migraine and headache-related disability among substance dependent inpatients.

Authors:  Michael J McDermott; Joshua C Fulwiler; Todd A Smitherman; Kim L Gratz; Kevin M Connolly; Matthew T Tull
Journal:  J Behav Med       Date:  2015-11-26

Review 2.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

3.  Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism.

Authors:  Ruth Defrin; Miri Riabinin; Yelena Feingold; Shaul Schreiber; Chaim G Pick
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

4.  Antinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor.

Authors:  Justin N Siemian; Samuel Obeng; Yan Zhang; Yanan Zhang; Jun-Xu Li
Journal:  J Pharmacol Exp Ther       Date:  2016-04-07       Impact factor: 4.030

5.  Microglia disrupt mesolimbic reward circuitry in chronic pain.

Authors:  Anna M W Taylor; Annie Castonguay; Alison J Taylor; Niall P Murphy; Atefeh Ghogha; Christopher Cook; Lihua Xue; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 6.  Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder.

Authors:  Joel Katz; Brittany N Rosenbloom; Samantha Fashler
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

7.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

Review 8.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

9.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

Review 10.  Pediatric fear-avoidance model of chronic pain: foundation, application and future directions.

Authors:  Gordon J G Asmundson; Melanie Noel; Mark Petter; Holly A Parkerson
Journal:  Pain Res Manag       Date:  2012 Nov-Dec       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.